The DCTN1 gene neuronopathy, also known as Distal Hereditary Motor Neuropathy Type 7B (dHMN7B), is a rare genetic disorder characterized by progressive weakness and atrophy of the distal muscles, primarily affecting the lower limbs. It is caused by mutations in the DCTN1 gene, which plays a crucial role in the structure and function of neurons, particularly in the transport of materials within the nerve cells.
To diagnose this condition, a genetic test is available at DNA Labs UAE, which specifically looks for mutations in the DCTN1 gene. The test is essential for confirming the diagnosis, understanding the disease progression, and making informed decisions regarding the management and treatment of the condition. It can also provide valuable information for family planning and the assessment of risk in family members.
The cost of the DCTN1 gene neuronopathy genetic test at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or a cheek swab, and its subsequent analysis in the laboratory. The test is conducted with high precision and confidentiality, ensuring accurate results that can significantly impact the management of Distal Hereditary Motor Neuropathy Type 7B.
The DNMT1 Gene Neuropathy Sensor Type 1E Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the DNMT1 gene, which are linked to the development of Hereditary Sensory Neuropathy Type 1E (HSN1E). HSN1E is a rare genetic disorder characterized by sensory loss, muscle weakness, and various neurological impairments that can significantly affect an individual's quality of life. The test involves analyzing the patient's DNA to detect any genetic anomalies within the DNMT1 gene that are known to cause this condition. With a cost of 4400 AED, the test provides crucial information for the accurate diagnosis and management of HSN1E, enabling targeted treatment strategies and genetic counseling for affected individuals and their families. DNA Labs UAE, with its state-of-the-art facilities and expertise in genetic diagnostics, ensures reliable and precise results for patients undergoing this test.
The PMP22 Gene Neuropathy with Liability to Pressure Palsies (HNPP) Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is specifically designed to identify mutations in the PMP22 gene, which are known to cause HNPP, a condition characterized by recurrent episodes of numbness, tingling, and muscle weakness. These symptoms are typically triggered by minor physical pressures on the nerves, such as leaning on elbows, crossing legs, or carrying heavy objects.
HNPP is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the PMP22 gene can lead to the disorder. The test involves analyzing the patient's DNA, extracted from a blood sample, to look for the specific genetic changes associated with HNPP. It is a critical tool for confirming a diagnosis, especially in individuals who exhibit symptoms of nerve compression and entrapment.
At DNA Labs UAE, the PMP22 Gene Neuropathy with Liability to Pressure Palsies (HNPP) Genetic Test is offered at a cost of 4400 AED. The test is conducted with high precision and accuracy, ensuring reliable results for patients and healthcare providers. Identifying the genetic basis of HNPP can significantly impact the management and treatment of the condition, allowing for personalized care strategies and prevention of further nerve damage through lifestyle adjustments and monitoring.
The "POLG Gene Neuropathy with Sensory Ataxic Dysarthria and Ophthalmoparesis Genetic Test" is a sophisticated diagnostic procedure aimed at detecting mutations in the POLG gene, which are associated with a spectrum of neurological disorders. The POLG gene plays a crucial role in the replication and repair of mitochondrial DNA. Mutations in this gene can lead to a range of symptoms including neuropathy (nerve damage), sensory ataxia (loss of coordination due to nerve damage), dysarthria (difficulty speaking), and ophthalmoparesis (weakness or paralysis of the eye muscles).
This comprehensive genetic test is crucial for individuals exhibiting these symptoms, as it can provide a definitive diagnosis, enabling tailored treatment and management plans. Early detection and intervention can significantly improve the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the POLG gene. Individuals undergoing this test can expect a reliable and thorough analysis, facilitating informed decisions about their health and treatment options.
The BSCL2 Gene Neuropathy Distal Hereditary Motor Type 5A Genetic Test is a specific diagnostic tool available at DNA Labs UAE, designed to identify mutations in the BSCL2 gene, which are associated with Distal Hereditary Motor Neuropathy Type 5A (dHMN-V). This condition is a rare genetic disorder characterized by progressive weakness and atrophy of the distal muscles, primarily affecting the lower limbs and, in some cases, the hands. The test plays a crucial role in confirming the diagnosis, enabling early intervention and management strategies for affected individuals.
Priced at 4400 AED, the test involves analyzing the patient's DNA sample to look for specific genetic alterations in the BSCL2 gene that are known to cause the disorder. The process helps in understanding the genetic basis of the condition, which can be crucial for family planning and determining the risk of passing the mutation to future generations. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, this test represents a significant step forward in the personalized care and management of genetic neuromuscular disorders.
The SPTLC2 Gene Neuropathy Hereditary Sensory and Autonomic Type 1C Genetic Test is a specialized diagnostic examination designed to identify mutations in the SPTLC2 gene, which are linked to the development of Hereditary Sensory and Autonomic Neuropathy Type 1C (HSAN1C). This condition is a rare genetic disorder characterized by a loss of sensory and autonomic functions, leading to symptoms such as insensitivity to pain, temperature, and touch, as well as autonomic dysfunctions.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test involves analyzing the patient's DNA to detect abnormalities in the SPTLC2 gene that can confirm the diagnosis of HSAN1C. The process is critical for patients exhibiting symptoms of sensory and autonomic neuropathy, as it allows for accurate diagnosis, which is essential for the management and treatment of the condition.
The cost of the SPTLC2 Gene Neuropathy Hereditary Sensory and Autonomic Type 1C Genetic Test at DNA Labs UAE is 4400 AED. This investment in health enables individuals and families affected by this condition to take informed steps towards managing the disorder, potentially improving the quality of life for those diagnosed. Given the complexity and rarity of HSAN1C, accessing precise genetic testing such as this offers a crucial pathway to understanding and addressing this challenging condition.
The SCN9A Gene Neuropathy Hereditary Sensory and Autonomic Type 2 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to detect mutations in the SCN9A gene. These mutations are associated with Hereditary Sensory and Autonomic Neuropathy Type II (HSAN2), a rare genetic disorder characterized by severe impairment of sensory and autonomic nervous system functions. This condition often leads to a loss of pain and temperature sensation, potentially resulting in unnoticed injuries and serious complications.
The test involves analyzing the patient's DNA to identify any genetic alterations in the SCN9A gene, which plays a critical role in the transmission of sensory and autonomic signals. By pinpointing specific mutations, the test can confirm a diagnosis of HSAN2, allowing for a better understanding of the condition and the development of a tailored management plan.
Offered at a cost of 4400 AED, this genetic test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability. It is a crucial tool for families with a history of the disorder, individuals presenting symptoms of sensory and autonomic dysfunction, or those seeking a definitive diagnosis for unexplained sensory issues. With this test, patients and healthcare providers can gain valuable insights into the genetic basis of HSAN2, paving the way for targeted interventions and improved quality of life.
The "DST Gene Neuropathy Hereditary Sensory and Autonomic Type 6 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the DST gene. These mutations are responsible for causing Hereditary Sensory and Autonomic Neuropathy Type VI (HSAN6), a rare genetic disorder. HSAN6 is characterized by sensory loss, autonomic dysfunction, and, in some cases, skin and bone abnormalities. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic alterations in the DST gene, providing crucial information for diagnosis, management, and genetic counseling of affected individuals and their families. This test is a valuable tool in the personalized approach to understanding and treating genetic neuropathies.
The ATL1 gene neuropathy hereditary sensory type 1D genetic test is a specialized diagnostic tool designed to identify mutations in the ATL1 gene, which are associated with hereditary sensory neuropathy type 1D (HSN1D). HSN1D is a rare genetic disorder characterized by sensory loss in the extremities, leading to significant discomfort, weakness, and in severe cases, amputation due to injury-related complications. This condition is inherited in an autosomal dominant manner, meaning that a mutation in just one of the two copies of the gene is sufficient to cause the disorder.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. With a cost of 4400 AED, the test is a critical resource for individuals with a family history of HSN1D or those exhibiting symptoms of sensory neuropathy. Early detection through this genetic test can aid in the management of symptoms and improve the quality of life for affected individuals by implementing preventive measures against complications.
DNA Labs UAE utilizes state-of-the-art technology to ensure accurate and reliable test results, offering crucial insights into the genetic underpinnings of hereditary sensory neuropathy type 1D. This test is an invaluable tool for genetic counselors, neurologists, and patients alike, providing a definitive diagnosis and facilitating informed decisions regarding treatment and management options.
The "ATL3 Gene Neuropathy Hereditary Sensory Type 1F Genetic Test" is a specialized diagnostic tool used to identify mutations in the ATL3 gene, which are associated with Hereditary Sensory Neuropathy Type 1F (HSN1F). HSN1F is a rare genetic disorder characterized by sensory loss in the extremities, leading to pain, weakness, and often injury due to the lack of sensation. The test involves analyzing the patient's DNA to pinpoint any genetic alterations in the ATL3 gene that could cause the condition. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides crucial information for the accurate diagnosis and management of HSN1F. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to identify these specific genetic changes. This test is essential for individuals showing symptoms of hereditary sensory neuropathy, as it aids in confirming the diagnosis, understanding the inheritance pattern, and potentially guiding treatment options.
